Latest / Bloomberg Intelligence / Jobs, Munis, and Ozempic
Transcript
- 0:00Speaker 1: Bloomberg is now on your dashboard with Apple CarPlay and
- 0:04Speaker 1: Android Auto. It gives you access to every Bloomberg podcast,
- 0:08Speaker 1: live audio feeds from Bloomberg Radio, print stories from Bloomberg
- 0:11Speaker 1: News in audio form, and the latest headlines of the
- 0:14Speaker 1: click of a button with Bloomberg News. Now it's free
- 0:18Speaker 1: with the latest version of the Bloomberg Business App. That's
- 0:21Speaker 1: the Bloomberg Business App. Get it on your phone in
- 0:24Speaker 1: the Apple App Store or on Google Play. Just download
- 0:27Speaker 1: the app, connect your phone to your car and get started.
- 0:30Speaker 1: And it's all presented by our sponsor, Interactive Brokers.
- 0:35Speaker 2: Welcome to the Bloomberg Markets Podcast. I'm Paul Sweeney. Alongside
- 0:38Speaker 2: my co host Matt Miller.
- 0:40Speaker 1: Every business day we bring you interviews from CEOs, market pros,
- 0:44Speaker 1: and Bloomberg experts, along with essential market moven News.
- 0:48Speaker 2: Find the Bloomberg Markets Podcast called Apple Podcasts or wherever
- 0:51Speaker 2: you listen to podcasts, and at Bloomberg dot com slash podcast.
- 0:55Speaker 2: Ben Emmons joins us here in our Bloomberg Interactive Broker studio.
- 0:59Speaker 2: He doesn't mail it in or own it, and he's
- 1:00Speaker 2: a principal, senior portfolio manager and head of fixed Income
- 1:03Speaker 2: at New Edge wealth. Been lots of economic data today
- 1:07Speaker 2: and really this week here I don't know. I mean
- 1:10Speaker 2: this services data kind of took me by surprise. Here
- 1:13Speaker 2: again the ism services data, and we talk about services,
- 1:16Speaker 2: it's important. It's seventy percent of our economy came in
- 1:19Speaker 2: at fifty point six, so it's still above fifty, still
- 1:21Speaker 2: showing some expansion in the economy, but well below last
- 1:25Speaker 2: month and well below the consensus of fifty two point five.
- 1:29Speaker 2: That's kind of got the bonds here, yields coming in
- 1:32Speaker 2: a little bit in stocks higher. What would you make
- 1:34Speaker 2: of that services data, yep.
- 1:35Speaker 3: Paul, I thought that the surprise there was that employment components,
- 1:38Speaker 3: you know, dropping below fifty free sharply.
- 1:40Speaker 2: Yep.
- 1:41Speaker 3: I think that's what that triggered the rally in bonds
- 1:44Speaker 3: because it's a bit contradicting to what we saw yesterday
- 1:48Speaker 3: with the b ANDI services data. Now, the surveys a
- 1:50Speaker 3: little different from each other, but nonetheless in the employment component,
- 1:54Speaker 3: that survey was up and it was actually I think
- 1:57Speaker 3: part of the reason why we saw about a payroll
- 1:59Speaker 3: data this morning. So I guess this survey is indicating that,
- 2:03Speaker 3: you know, some of the people in the supply management
- 2:07Speaker 3: survey view that the economy is perhaps getting weaker or
- 2:10Speaker 3: they're having less demand for labor. Either way, you're getting
- 2:12Speaker 3: this whipsite on the market this morning. You goes up
- 2:15Speaker 3: to four point ten on the ten year on the
- 2:17Speaker 3: pay roverboard and reverse back down between ninety six. So
- 2:21Speaker 3: I think what it tells us is that this is
- 2:23Speaker 3: a good economy. There will be some ray cuts coming
- 2:26Speaker 3: in the future, but it is not like a recession
- 2:29Speaker 3: economy either, so you're not see much lower yields I
- 2:32Speaker 3: think from here.
- 2:33Speaker 4: Yeah, So but let's get into the rate cuts that
- 2:35Speaker 4: you talked about. Because we have the jobs that we
- 2:37Speaker 4: have ism, you also get resource from Wall Street firms,
- 2:41Speaker 4: from banks, So when do you see these rate cuts
- 2:44Speaker 4: possibly kicking in it?
- 2:45Speaker 3: So I think the March raycut is probably too soon,
- 2:49Speaker 3: and that's just because the way the Fed is communicated
- 2:52Speaker 3: that so far, you know, they've given us an idea
- 2:54Speaker 3: that they are in projections out that probably gives them
- 2:58Speaker 3: the confidence that they can actually this year can lower
- 3:01Speaker 3: rates compared to last year when they said resoundingly like
- 3:04Speaker 3: there's no case for raycouts. But a March raycot would
- 3:08Speaker 3: mean that inflation data we're getting out until that time
- 3:11Speaker 3: would see such significant decline that they start reacting to
- 3:15Speaker 3: that and then make the case that March is the
- 3:17Speaker 3: live meeting. So I think from the here at LISA,
- 3:21Speaker 3: it will be more about as we're getting several months
- 3:24Speaker 3: of inflation employment data, and it could used to go
- 3:27Speaker 3: towards the you know, the goal that they have two
- 3:29Speaker 3: percent inflation and unemployment rate maybe a little bit above four.
- 3:32Speaker 3: That probably is more close to the June to get
- 3:35Speaker 3: the first ray cut and then we really are into
- 3:38Speaker 3: the second half of the year, So I don't think
- 3:40Speaker 3: you're going to see six raycouts this year. So, Ben,
- 3:43Speaker 3: what did you.
- 3:43Speaker 2: Make We haven't spoken to you in a while here.
- 3:45Speaker 2: What did you make of that big move we've saw
- 3:47Speaker 2: in the markets there in the last I don't know,
- 3:49Speaker 2: ten weeks of the year. Last year, we just had
- 3:51Speaker 2: the ten year ago from five percent to three and
- 3:53Speaker 2: a quarter. We had the stocks just rip. I mean,
- 3:56Speaker 2: what was that?
- 3:58Speaker 5: Yeah?
- 3:58Speaker 3: Actually the right right in a way to say, what
- 4:01Speaker 3: was it really about? Was it just about yields going down?
- 4:04Speaker 3: Because one CPI reports showed that the owner's equipmental event
- 4:09Speaker 3: finally starts to decline. I don't see it in New York.
- 4:11Speaker 3: But okay, it's it's finally declining. So that triggered the
- 4:16Speaker 3: move down and yields and there was a relief, and
- 4:18Speaker 3: you're getting all the high beta and small caps and
- 4:21Speaker 3: everything start to pricing this idea that yeah, Okay, the
- 4:24Speaker 3: economy is not going to go to a recession. It
- 4:26Speaker 3: will be a soft landing, maybe even no landing. I think,
- 4:28Speaker 3: because it's just simply an economy is staying on track.
- 4:31Speaker 3: And at the same time, it's about those who had
- 4:34Speaker 3: money on the sidelines redeploying in something that lacked relative
- 4:38Speaker 3: to technology, so sort of a relative catch up that
- 4:41Speaker 3: I think all I think what drove this rally. Now
- 4:45Speaker 3: will it continue is to be seen because I think
- 4:49Speaker 3: what we're coming into this year is that we're going
- 4:51Speaker 3: to keep a fat still restricted for a bit of time.
- 4:54Speaker 3: So the economy, if it does stay in the slower
- 4:57Speaker 3: track than last year, you know, you may see stocks
- 5:00Speaker 3: not perform so strongly. If it's a lie, she has
- 5:02Speaker 3: yields to sort of stay where we are, And I
- 5:04Speaker 3: think that there's a really important part about that story. Ultimately,
- 5:07Speaker 3: it's all about interest rates.
- 5:08Speaker 4: Now, but a strong drug jobs market. It's that main
- 5:12Speaker 4: kind of engine for resilient consumer spending, and it's pushed
- 5:15Speaker 4: a lot of economists to rethink their recession calls. What's
- 5:18Speaker 4: what's your take on that.
- 5:20Speaker 3: Yeah, I think the recession call, I've never been in
- 5:23Speaker 3: that camp. I still think there's no recession this year.
- 5:25Speaker 3: It may not even be next year. I think here's
- 5:28Speaker 3: where I come from. This important point to make maybe
- 5:30Speaker 3: is that the fiscal impulse that we have to the economy,
- 5:33Speaker 3: fiscal spending is not going to change this year. They
- 5:36Speaker 3: have agreed on the dead seating last year. They have
- 5:39Speaker 3: one percent mandatory spending cut across the board. But that's
- 5:42Speaker 3: so small if you think about back in twenty eleven
- 5:45Speaker 3: twelve when they had a ten percent mandatory spending cut,
- 5:48Speaker 3: which really slowed down the economy. One percent is just
- 5:51Speaker 3: not going to do much for the economy. Especially I've
- 5:53Speaker 3: seeing job stated like this coming out, and you're seeing
- 5:56Speaker 3: confidence picking up and financial conditions being looser. So I
- 6:01Speaker 3: think it's an economy that stays on track. What could
- 6:04Speaker 3: change it is next year whomever was in the White House.
- 6:06Speaker 3: But here's one other things about that White House race,
- 6:09Speaker 3: the new president. But it's buy no Trump, which what
- 6:13Speaker 3: it looks like either of them wants to stimulate the economy,
- 6:15Speaker 3: either with text cuts or with more spending. So either way,
- 6:18Speaker 3: I think this recession scenario is not going to play
- 6:20Speaker 3: out unless we getting major fiscal spending contraction. As I mentioned,
- 6:25Speaker 3: I don't think that's the case.
- 6:27Speaker 2: So given that backdrop, Ben kind of what's your best
- 6:31Speaker 2: idea here? Coming into twenty twenty four, A lot of
- 6:33Speaker 2: folks were saying, hey, just be long equity markets, but
- 6:35Speaker 2: then you had that huge run up in the end
- 6:37Speaker 2: of the year and maybe some of the glory was
- 6:39Speaker 2: taken out of there. What's your best idea or do
- 6:42Speaker 2: you think about twenty four?
- 6:43Speaker 3: Well, we do look carefully at new edge valuations, and
- 6:46Speaker 3: you know MC colleague Cameron Dawson who was on Bloomberg's
- 6:49Speaker 3: events the other day, she kind of make the case
- 6:51Speaker 3: on that too. It's saying, look, we do have overvaluation
- 6:54Speaker 3: in tech and the adjustment of interest rates a bit higher.
- 6:57Speaker 3: For me, I guess economy, it's just better takes off
- 7:00Speaker 3: some of that that that valuation fraft that's in there
- 7:03Speaker 3: with those also some I think some level of frath
- 7:05Speaker 3: coming into uh you know, really Higbida elements of the market,
- 7:10Speaker 3: so I think you want to play it more a
- 7:12Speaker 3: bit more defense. We like energy, we like utility sector,
- 7:16Speaker 3: like some of the healthcare sector. You really pick your
- 7:18Speaker 3: best parts there. There's very some stocks are very undervalued
- 7:22Speaker 3: relative to the marketing, trading really at low multiples, and
- 7:25Speaker 3: actually the earning forecast much were realistic.
- 7:27Speaker 2: So not chasing. I guess those magnificent seven.
- 7:31Speaker 3: Not not really so to the call like, yeah, jefferis
- 7:34Speaker 3: like Microsoft. We all know that Microsoft is a great company.
- 7:37Speaker 3: It's good and strong, but you will be chasing it
- 7:39Speaker 3: probably here at these valuation levels. But I like and
- 7:44Speaker 3: fixed income, and also I think inequity is that emerging
- 7:46Speaker 3: markets is an interesting story because we are coming off
- 7:49Speaker 3: really restrictive rates in emerging markets and inflation is really moderated.
- 7:53Speaker 6: There.
- 7:54Speaker 3: There's some really good earning growth stories both Asia and
- 7:56Speaker 3: Latin America, so I think there's an opportunity. We like Japan,
- 8:00Speaker 3: there's another market that's contasued to be outperformer. And international equity.
- 8:05Speaker 3: And then lastly, we gotta watch what the dollar is
- 8:07Speaker 3: going to do this year. If the Fat's going to
- 8:09Speaker 3: lower rates, it's gonna lead like into a week a
- 8:12Speaker 3: dollar environment every time the dollar does go below a
- 8:15Speaker 3: haunted on the index, it leads to significant rally and
- 8:18Speaker 3: energy and commodities. It's been that historically that way. I
- 8:21Speaker 3: don't think it's going to be different this way this
- 8:24Speaker 3: year and now whatever happens with ge politically, Energy is
- 8:28Speaker 3: I think a bit unvalued from where it is currently.
- 8:30Speaker 3: Same thing some someone in commodities. Lastly, gold could actually
- 8:34Speaker 3: be a strong air for gold given uncertainty and fat
- 8:37Speaker 3: easy it performs quite well in that environment.
- 8:41Speaker 4: And just a quick I want to get an idea
- 8:42Speaker 4: of sentiment out there. I mean, you think rising interest
- 8:45Speaker 4: rates makes it more expensive for companies to operate. I
- 8:47Speaker 4: mean some of your clients, they're entrepreneurs, their corporate executives.
- 8:51Speaker 4: What's the feeling that they're getting out there?
- 8:54Speaker 3: Now, Wow, there's caution and nowice this. Obviously, we do
- 8:57Speaker 3: deal with this election and it's it's uncertainty. We also
- 9:01Speaker 3: just do the fat discussion. It's not clear right if
- 9:04Speaker 3: you're actually going to get these raycouts and how many
- 9:06Speaker 3: uncertainty while watching what's going on in the Middle East,
- 9:10Speaker 3: and we don't know how that's going to exactly play out.
- 9:12Speaker 3: So uncertainty. On the other hand, there doesn't seem to
- 9:16Speaker 3: be this slowdown that everybody can teach to talk about
- 9:20Speaker 3: that the solda and that tips us into a recession.
- 9:22Speaker 3: So I think that our clients are more about, you know,
- 9:25Speaker 3: we like risk. We'd like to not be out of
- 9:28Speaker 3: the market. We still like some of the areas like
- 9:31Speaker 3: private credit or private equity. That's not something we want
- 9:34Speaker 3: to necessarily skill completely out of it because of recession risk.
- 9:37Speaker 3: But we don't want you to play the high beta
- 9:40Speaker 3: trade either, and meaning you know, going reading in high
- 9:43Speaker 3: risk really small small small caps or you know, go
- 9:46Speaker 3: into I don't know crypto and things like that. You know,
- 9:49Speaker 3: we don't want to play the liquidity high risk game
- 9:52Speaker 3: that way, and be mindful that we do have fixed income.
- 9:55Speaker 3: We can we can finally get some additional income that's
- 9:57Speaker 3: still really important in the portfolio this year.
- 10:00Speaker 2: Thanks so much for joining us, Benham's principal at New
- 10:03Speaker 2: Edge Wealth.
- 10:05Speaker 5: You're listening to the team Ken's a our live program,
- 10:08Speaker 5: Bloomberg Markets weekdays at ten am Eastern on Bloomberg dot com,
- 10:12Speaker 5: the iHeartRadio app, and the Bloomberg Business app, or listen
- 10:15Speaker 5: on demand wherever you get your podcasts.
- 10:20Speaker 2: There is no greater friend to the municipal bond market
- 10:22Speaker 2: than me. I tell every governor of the State of
- 10:25Speaker 2: New Jersey, I'm probably the largest private creditor to the
- 10:28Speaker 2: State of New Jersey through my municipal bond holdings. Chris
- 10:31Speaker 2: Burgante Brigatti, he thinks he knows a thing or two
- 10:33Speaker 2: about it. But Senior vice president Director Strategic Planning at SWBC, Hey, Chris,
- 10:38Speaker 2: thanks so much for joining us here in studio. Fixed
- 10:41Speaker 2: income actually had a positive year last year in terms
- 10:44Speaker 2: of total return. How did the municipal bond market do?
- 10:46Speaker 7: The municipal bond market had a very good year, and
- 10:49Speaker 7: it all really happened in the last two months of
- 10:51Speaker 7: the year. It was negative coming into and through October,
- 10:53Speaker 7: so the performance actually turned quite positive about six point
- 10:56Speaker 7: four percent to the positive by the end of the
- 10:58Speaker 7: year with over seven percent return is coming in November December.
- 11:02Speaker 2: All right, So what are we doing here with the
- 11:03Speaker 2: unicipal bond market in twenty twenty four. What's the call here?
- 11:08Speaker 7: The call is to be very strategic in terms of
- 11:10Speaker 7: how you approach a market and delegate your capital. A
- 11:13Speaker 7: lot of the investors that we're talking to and a
- 11:15Speaker 7: lot of the people that we engaged directly, are really
- 11:17Speaker 7: kind of being very cautious on their credit approach, not
- 11:21Speaker 7: really going too far out on the credit curve because
- 11:23Speaker 7: those credit spreads and narrow significantly in the rally through
- 11:25Speaker 7: November and December. So now it's a matter of when
- 11:28Speaker 7: can you re engage the market in a more strategic
- 11:30Speaker 7: manner further out the curve or down the credit curve,
- 11:32Speaker 7: And I think both of those opportunities could happen this year.
- 11:35Speaker 7: But I do expect this to be another quite constructive
- 11:37Speaker 7: year for the market in general.
- 11:39Speaker 2: So what else are we doing in the fixed the
- 11:41Speaker 2: gum space here, because I you know, twenty twenty two
- 11:45Speaker 2: is so brutal for across fixed income space, double digit
- 11:47Speaker 2: declines declient is like the fixing the market had never
- 11:50Speaker 2: really seen had some positive results in twenty twenty three.
- 11:54Speaker 2: Any reason for me to own bonds here in twenty twenty.
- 11:56Speaker 7: Four, I think there still are. You know, you look
- 11:58Speaker 7: at the fact that we've got real good yields that
- 12:01Speaker 7: we have not seen in well over a decade. So
- 12:03Speaker 7: for a longer term perspective, you start looking at that,
- 12:05Speaker 7: and you know, if you're going to be clipping coupons
- 12:08Speaker 7: and be able to grab that four percent yield if
- 12:09Speaker 7: rates remained unchanged, barring the expectation for lower rate environment,
- 12:14Speaker 7: which would add additional performance to a bond. If you
- 12:16Speaker 7: can lock in four percent or better type of yields
- 12:18Speaker 7: in this market, you're really looking at strong performance in chase.
- 12:21Speaker 4: Dig a little bit deeper into what banks are doing
- 12:24Speaker 4: with some of them munity teams.
- 12:26Speaker 2: Your city they announced at getting out of the municipal
- 12:29Speaker 2: ball market. They did they can't do that.
- 12:31Speaker 7: It's amazing they've they've made that announcement in backing out
- 12:34Speaker 7: of the market. I mean the market is becoming tougher
- 12:36Speaker 7: and tougher, spreads are narrow, it's becoming much more constrained.
- 12:39Speaker 7: Regulators aren't helping. I'm not going to really kind of
- 12:42Speaker 7: go down that path too deeply, but it's a challenging
- 12:44Speaker 7: market for banks to make money in. And so the
- 12:47Speaker 7: strategy and the way you approach it is how can
- 12:49Speaker 7: you embed yourself deeper and better with clients to provide
- 12:51Speaker 7: better service. And that's one of the goals that we're
- 12:54Speaker 7: trying to produce at SWBC is how can we ingrain
- 12:57Speaker 7: ourselves as a partner to those clients and really add
- 12:59Speaker 7: value SBbc stand for Southwest Business Court.
- 13:02Speaker 2: Southwest where you guys based.
- 13:04Speaker 7: San Antonio, Texas's headquarter.
- 13:06Speaker 3: Nice?
- 13:06Speaker 2: Is that where you're from?
- 13:07Speaker 3: No?
- 13:07Speaker 7: No, I'm Northern New Jersey.
- 13:08Speaker 2: Here in northern New Jersey. Okay, I'm a big fan
- 13:10Speaker 2: of San anton all right. So in the I don't
- 13:15Speaker 2: know where are we going to see a new issuance
- 13:16Speaker 2: this year? I mean, am I going to see a
- 13:17Speaker 2: bunch of new fixed income issueans, credit issuance? High yield
- 13:22Speaker 2: municipal bonds? Am I going to see a bunch of issuance?
- 13:24Speaker 2: Now that interest rates are coming down? Do you think?
- 13:26Speaker 6: I think so?
- 13:26Speaker 7: I think the opportunity for issuance to rise is twofold
- 13:30Speaker 7: when you look at what happened with the taxable municipal
- 13:32Speaker 7: market last year, which was down about thirty percent in
- 13:34Speaker 7: terms of issuance. So I expect that to rebound a
- 13:37Speaker 7: little bit. Last year, issuance came in around three hundred
- 13:39Speaker 7: and eighty billion dollars, which was a few percentage points
- 13:42Speaker 7: lower than the previous year in twenty two. I expect
- 13:44Speaker 7: this year to be a little bit north of four hundred.
- 13:47Speaker 2: And an average year is like five six hundred.
- 13:49Speaker 7: No, an average year of late has been somewhere in
- 13:51Speaker 7: that mid to.
- 13:51Speaker 2: Low force mid force.
- 13:53Speaker 7: Yeah, yeah, so I expect to get more towards the
- 13:54Speaker 7: average and the opportunity for investors who engage that should
- 13:58Speaker 7: be well stated.
- 14:00Speaker 2: But the municipal bond like I've been told in the
- 14:01Speaker 2: past that municipal bond issuers, municipalities, they don't issue money
- 14:06Speaker 2: when rates are low per se, they issue money when
- 14:10Speaker 2: they need it. Correct, So aren't we having a bunch
- 14:13Speaker 2: of like infrastructure acts and things like that. Don't have
- 14:17Speaker 2: a bunch of stuff going from the federal grim that
- 14:19Speaker 2: needs to be funded in municipal bond market.
- 14:21Speaker 7: There are You know, it's funny when the infrastructure bill
- 14:23Speaker 7: came out several years ago, the market got all heady
- 14:25Speaker 7: and for lack of a better way of putting it, in
- 14:27Speaker 7: terms of the opportunity for more issuance to come. But
- 14:30Speaker 7: those infrastructure things take time to build. It takes years
- 14:33Speaker 7: to get through the system through the process at local
- 14:36Speaker 7: or even larger municipalities to be able to construct that
- 14:39Speaker 7: new road, to do something with a bridge. All those
- 14:42Speaker 7: infrastructure projects take time to even get started. So once
- 14:45Speaker 7: they get started, that's when the borrowing is going to happen,
- 14:47Speaker 7: and I think that we kind of got through twenty
- 14:49Speaker 7: twenty three with the huge spiking yields we saw in
- 14:52Speaker 7: October that scared a lot of people. Now that it's
- 14:54Speaker 7: kind of more normalized, I think that the issuers are
- 14:56Speaker 7: going to come back into the market, and they, like
- 14:58Speaker 7: you said, they're going to come in when they have
- 15:00Speaker 7: and when they don't have to and rates are high,
- 15:02Speaker 7: they stayed as far away as they can. So now
- 15:05Speaker 7: it's the opportunity is going to be there, and I
- 15:06Speaker 7: think they're going to come in quite strongly.
- 15:08Speaker 2: So who are buyers of municipal bonds these days? I'm
- 15:12Speaker 2: likely retail versus institutional. How does that split look today
- 15:14Speaker 2: and maybe how's that changed over the last decade or so.
- 15:17Speaker 7: Yeah, you know, that's one of the most interesting things,
- 15:18Speaker 7: and that's one of the things we're trying to be
- 15:19Speaker 7: aware of at SWBC is the retail investor has historically
- 15:23Speaker 7: been a strong participant in the municipal market. Their participation
- 15:27Speaker 7: has shifted less away from the funds. ETFs have kind
- 15:32Speaker 7: of picked up some of the fund bandwidth and fund opportunity,
- 15:35Speaker 7: but the small accounts that are managed by portfolio managers,
- 15:40Speaker 7: so they're professionally managed, but it's an SMA. Those types
- 15:43Speaker 7: of accounts are really where most of the opportunity is,
- 15:45Speaker 7: and that has grown by more than double in the
- 15:47Speaker 7: past several years. So those investors are really participating strongly
- 15:51Speaker 7: and reaping the benefits tax for yield.
- 15:54Speaker 2: What's not to like, Yeah, exactly. And so what's the
- 15:57Speaker 2: credit quality in the municipal space. I'm actually surprised. I mean,
- 16:00Speaker 2: always the Puerto Rico issue or something out of Illinois
- 16:02Speaker 2: or something like that. But other than some of those
- 16:04Speaker 2: weird situations, I haven't heard of any cracks of note
- 16:08Speaker 2: in the municipal bond market really for years.
- 16:11Speaker 7: It's been several years, you know. You look at the
- 16:13Speaker 7: fact that the federal government allowed for some of the
- 16:16Speaker 7: infrastructure bill, some of the opportunity for federal aid or
- 16:20Speaker 7: during the pandemic and COVID, so a lot of issuers
- 16:22Speaker 7: have built up a reserve of funds as a result
- 16:25Speaker 7: of that. So the credits are actually quite high, higher
- 16:28Speaker 7: than they possibly would otherwise be. But generally the municipal
- 16:31Speaker 7: market is really really solid footing. I mean, most of
- 16:33Speaker 7: the space could take most of the investment and opportunity
- 16:36Speaker 7: to take space in the double triple B and higher
- 16:38Speaker 7: investment grade. That's where the vast majority of issuance is
- 16:41Speaker 7: and the default rate on those is less than one percent.
- 16:45Speaker 7: So the only thing time you hear about something like
- 16:47Speaker 7: that is sketch your credits in odd different markets. Healthcare
- 16:51Speaker 7: is notoriously a challenge some of the housing market as well.
- 16:54Speaker 7: And then you get the odd issuers and the Puerto
- 16:56Speaker 7: Rico story I always rears its head.
- 16:58Speaker 2: Then there's the ball across the river there.
- 17:00Speaker 8: Exactly what's going on with that?
- 17:01Speaker 2: What's the dream mall? I think, yeah, yeah, somebody would.
- 17:04Speaker 2: I mean, that is fascinating to me. I remember when
- 17:07Speaker 2: that issue came to market, I said, I know nothing
- 17:10Speaker 2: about the dream mall. I know nothing about the municipal
- 17:12Speaker 2: bond market, but I wouldn't go near that bond issuance.
- 17:15Speaker 2: I mean, I couldn't see how that thing would actually
- 17:18Speaker 2: be successful, much less pay me back my principle.
- 17:20Speaker 3: Have you been there?
- 17:21Speaker 8: No, that's still nice.
- 17:22Speaker 2: That's the point either.
- 17:23Speaker 7: I know, you know, it's in a tough location for
- 17:26Speaker 7: New Yorkers especially, it's it's not easier fund to go
- 17:29Speaker 7: over the bridge and then travel through there. And you know,
- 17:32Speaker 7: my kids have been there to go on some of
- 17:33Speaker 7: the rides and do some of those things, and they
- 17:35Speaker 7: enjoy it. But I haven't stepped foot in myself either.
- 17:37Speaker 7: And it's a tough credit, that's for sure.
- 17:39Speaker 6: All Right.
- 17:40Speaker 2: What are some of the sectors that you think are
- 17:41Speaker 2: going to be interesting in twenty twenty four?
- 17:45Speaker 7: You know, I always mention things that are quality revenue
- 17:48Speaker 7: bonds that I really like, and you know, you go
- 17:50Speaker 7: down the path of water and sewer bonds. Everyone has
- 17:52Speaker 7: to pay their water bill, it needs to or so
- 17:54Speaker 7: I think in terms of higher credit quality, that's definitely
- 17:57Speaker 7: on the plate. I think that office opportunity, other things
- 17:59Speaker 7: that make sense, or some of the better higher quality
- 18:01Speaker 7: education bonds the well known names for lack of a
- 18:04Speaker 7: better way of putting it, and then transportation transportation revenue bonds,
- 18:08Speaker 7: bigger airport revenue bonds, those sorts of things are going
- 18:10Speaker 7: to be on the uptrend, I believe.
- 18:12Speaker 2: How about education, because we've seen some stories about how
- 18:15Speaker 2: if you're a small, mid size liberal arts college, that's
- 18:20Speaker 2: a tough business. And I've seen some issuance. I've seen
- 18:22Speaker 2: some issuance from secondary schools, prep schools and things like that.
- 18:25Speaker 2: I can't remember which the issue was, but one of
- 18:27Speaker 2: the top prep schools. How about those education back bonds?
- 18:30Speaker 2: How do you think about those?
- 18:32Speaker 7: You know, to your point, it depends on the name
- 18:34Speaker 7: and ten bands on the issuer and the credit you
- 18:36Speaker 7: really got and kind of understand and digg into weeds
- 18:38Speaker 7: a little bit to understand what is the underlying credit
- 18:40Speaker 7: quality of each one. And to your point, you know,
- 18:43Speaker 7: you stick to the higher names that are very well
- 18:45Speaker 7: known the place where it's ivy leagues, et cetera. You know,
- 18:48Speaker 7: those names stand up very well. They have very strong participation,
- 18:51Speaker 7: Their endowment programs are enormous, and when you look at
- 18:55Speaker 7: their acceptance rates, they still have low acceptance percentages, meaning
- 18:59Speaker 7: a lot of people still want to go there and
- 19:01Speaker 7: very few still get in. You look down the curve
- 19:03Speaker 7: and you start looking at some of the less well
- 19:05Speaker 7: known issuers.
- 19:07Speaker 6: The liberal arts colleges.
- 19:08Speaker 7: That you mentioned, they're having a tougher time attracting retaining people,
- 19:11Speaker 7: and I think COVID was not helpful for that construct.
- 19:14Speaker 7: They definitely suffered in terms of people wanting to go
- 19:17Speaker 7: to college and or how they engage colleges directly.
- 19:20Speaker 2: So just real quick on Puerto Rico, are they out
- 19:22Speaker 2: of the woods yet, I can't remember kind of where
- 19:23Speaker 2: we are there.
- 19:25Speaker 7: Yeah, they're not quite out of the woods yet. That
- 19:27Speaker 7: story seems to be the story that never ends. So
- 19:29Speaker 7: they're in challenging times. There's constant discussions over you know,
- 19:33Speaker 7: what's going to happen with the debt service and who's
- 19:35Speaker 7: going to be paying it and who's responsible, and then
- 19:37Speaker 7: what is the restructuring going to look like? And you know,
- 19:40Speaker 7: that's getting into the weaths of it. Very challenging, yeah stuff.
- 19:42Speaker 2: Luckily, we have the Joe Mysak who covers the municipal
- 19:46Speaker 2: bond mark for like a goajillion years at Bloomberg News,
- 19:49Speaker 2: and he keeps us up to date on what's happening there,
- 19:51Speaker 2: so we appreciate that. Chris Burgotti, thanks for joining us.
- 19:53Speaker 2: Christoph Gotti is a senior vice president, director of Strategic
- 19:56Speaker 2: Planning at SWBC based in San Antonio.
- 20:00Speaker 5: Listening to the tape Cat's are live program Bloomberg Markets
- 20:03Speaker 5: weekdays at ten am Eastern on Bloomberg Radio, the tune
- 20:06Speaker 5: in app, Bloomberg dot Com, and.
- 20:08Speaker 6: The Bloomberg Business App.
- 20:09Speaker 5: You can also listen live on Amazon Alexa from our
- 20:12Speaker 5: flagship New York station just say Alexa play Bloomberg eleven thirty.
- 20:19Speaker 2: All right, the two teams from twenty twenty one from
- 20:21Speaker 2: a stock market perspective for me, that just came out
- 20:23Speaker 2: of nowhere. One was AI okay, of course, and the
- 20:26Speaker 2: other one is this weight loss stuff the GLP ones.
- 20:29Speaker 4: Now it's EMPI gov.
- 20:31Speaker 2: I mean, you're a workout Maven, so this is a
- 20:33Speaker 2: non issue for you. But for a lot of people
- 20:36Speaker 2: it's huge. I could see how this could just be massive,
- 20:39Speaker 2: particularly if they get into a pill format. My question
- 20:42Speaker 2: is always who pays for it? Simone Foxman, reporter for
- 20:46Speaker 2: Bloomberg News, TV radio and all that kind of stuff.
- 20:48Speaker 2: She's everywhere. She did a lot of reporting on this,
- 20:51Speaker 2: has got a great story out on the Bloomberg terminal
- 20:54Speaker 2: here she joins us live here in our Bloomberg Interactive
- 20:56Speaker 2: Brokers studio. Simone, help us figure out, because I think
- 21:00Speaker 2: you can make an argument that almost well get jillions
- 21:03Speaker 2: of people in the US in theory would want to
- 21:06Speaker 2: take this drug, will want to take this drug, are
- 21:08Speaker 2: taking this drugg But my question is who pays for it?
- 21:10Speaker 2: How does that all work?
- 21:11Speaker 6: Well?
- 21:12Speaker 9: So there are different classes of people, right, you have
- 21:14Speaker 9: your people who are insured and their employers maybe pay
- 21:17Speaker 9: for their healthcare, and some of them who are insured
- 21:20Speaker 9: pay for it themselves. Then you have, you know, people
- 21:23Speaker 9: on Medicare, and then you have eighty five million people
- 21:27Speaker 9: low income people typically on Medicaid. And this is the
- 21:31Speaker 9: area that we really dive into as well as some
- 21:34Speaker 9: of those insured people, because a lot of this burden
- 21:38Speaker 9: is going to fall on states. States spend on average
- 21:41Speaker 9: over a quarter of their overall state budget on healthcare costs,
- 21:47Speaker 9: and those you know, for many states, including New York,
- 21:49Speaker 9: are skyrocketing, and it turns out, you know, this is
- 21:52Speaker 9: going to be a larger and larger part of their
- 21:55Speaker 9: budget as they try and pay for Medicaid costs, which
- 21:58Speaker 9: is part of is a respect ability they have. They
- 22:01Speaker 9: contribute to that as well as their own state employees.
- 22:04Speaker 9: Now right now, most insurers, this is private, public, et cetera,
- 22:09Speaker 9: pay for GLP ones for people with type two diabetes.
- 22:14Speaker 2: But the whole.
- 22:15Speaker 9: Idea that we have been hearing from Wall Street is
- 22:18Speaker 9: people who just are seeking this for weight loss, who
- 22:21Speaker 9: are overweight, They're the ones that are ultimately going to
- 22:23Speaker 9: be seeking this and that's why this is such a
- 22:25Speaker 9: massive market.
- 22:26Speaker 4: Yeah, the cosmetic weight loss, I mean exactly likely. They
- 22:29Speaker 4: came out yesterday and they warned about people doing it
- 22:32Speaker 4: for this, but.
- 22:32Speaker 9: It's but it's not just cosmetic weight loss. It should
- 22:35Speaker 9: be very if you know, noted that this has all
- 22:38Speaker 9: these variety of health benefits. Uh, the twenty percent reduction
- 22:42Speaker 9: that a Novo Nordisks showed among patients who had a
- 22:47Speaker 9: health had a heart condition or some history of heart
- 22:50Speaker 9: disease as well as obesity, you know, that's an enormous
- 22:55Speaker 9: savings potentially for insurers, including public insurers. But at a
- 23:01Speaker 9: cost of one thousand dollars a month. That's the shrugs.
- 23:04Speaker 2: That's the number that jumped out of meat from your reporting.
- 23:06Speaker 2: One thousand dollars a month. And you know a lot
- 23:08Speaker 2: of these you know, government officials saying that's going to
- 23:11Speaker 2: we don't have that money.
- 23:13Speaker 9: And the first government officials that were really starting to
- 23:15Speaker 9: hear from are the ones who control the state health plans. Again,
- 23:20Speaker 9: not every state health plan covers this for weight loss.
- 23:23Speaker 9: They almost all do for subject to restrictions for type
- 23:26Speaker 9: two diabetes. But the ones who do, including North Carolina
- 23:30Speaker 9: and Connecticut, have both flagged that this is a real
- 23:33Speaker 9: rising cost and in North Carolina this was a subject
- 23:37Speaker 9: of very heated meeting over whether or not they should
- 23:40Speaker 9: continue covering these drugs for weight loss at all, and
- 23:44Speaker 9: ultimately they decided anyone who was on it up till
- 23:46Speaker 9: January first can stay on it for that reason. But
- 23:51Speaker 9: people who are just seeking these for weight loss beyond
- 23:54Speaker 9: this specifically.
- 23:56Speaker 2: You got some crazy numbers in here, just in terms
- 23:58Speaker 2: of the medicage growing GLP one bill. Here are the
- 24:02Speaker 2: numbers in twenty twenty three point three billion, in twenty
- 24:05Speaker 2: twenty one five billion, and in twenty twenty two seven
- 24:08Speaker 2: point nine billion.
- 24:09Speaker 9: So that's just we medicate, and we have some limited
- 24:12Speaker 9: data for twenty twenty three. I can tell you already
- 24:15Speaker 9: the nut number is bigger.
- 24:16Speaker 3: Wow.
- 24:16Speaker 9: But here's the thing.
- 24:17Speaker 4: You have to be on this drug forever. This is
- 24:21Speaker 4: not a one time thing a couple of months. No,
- 24:23Speaker 4: you have to continue to be on this correct.
- 24:25Speaker 3: Yeah.
- 24:25Speaker 9: And the thing is, you know some of these costs,
- 24:28Speaker 9: the costs that you just mentioned, Paul, A lot of
- 24:31Speaker 9: these are driven by type two diabetes patients. In fact, uh,
- 24:36Speaker 9: why I was going through these numbers. The biggest driver
- 24:39Speaker 9: of that increase that you talk about between twenty twenty
- 24:42Speaker 9: and twenty twenty two is for a drug called Trullicity.
- 24:45Speaker 9: This is a GOLP one that has has been out
- 24:47Speaker 9: there may cause some weight loss, but it's not the ozembic,
- 24:50Speaker 9: it's not the wee goov, it's not the one with
- 24:52Speaker 9: all this name recognition really for weight loss. So it's
- 24:54Speaker 9: there's still a long way to go. If we just
- 24:57Speaker 9: are to cover all the type two diabetes patients, and
- 25:00Speaker 9: we calculate it in our analysis that that bill if
- 25:03Speaker 9: all the type two diabetes patients that actually deserve this,
- 25:06Speaker 9: according to the research, were covered, that would be forty
- 25:09Speaker 9: one billion dollars for Medicaid alone. Don't we can't even
- 25:12Speaker 9: take in state healthcare plans there.
- 25:14Speaker 2: I mean, I'm not sure how to do the math
- 25:17Speaker 2: or I'm sure it's being done within the healthcare industry.
- 25:19Speaker 2: But if more people are on these GLP one drugs, Okay,
- 25:22Speaker 2: that's an incremental cost and can the system bear that?
- 25:25Speaker 2: But you offset that by presumably some of the issues
- 25:29Speaker 2: they won't have to deal with, you know, obesit, diabetes,
- 25:33Speaker 2: things like that, And that goes down to I've even
- 25:36Speaker 2: seen medical device companies stocks sell off because there'll be
- 25:39Speaker 2: less knee replacements, hip replacements, all that kind of thing.
- 25:43Speaker 2: I'm not sure how to quantify that benefit versus what
- 25:45Speaker 2: I know is the upfront cost.
- 25:46Speaker 9: This is an incredibly problematic analysis. We know that obesity
- 25:53Speaker 9: itself is very expensive. Diabetes is three hundred and twenty
- 25:58Speaker 9: seven billion dollars in medical cost a year. That's one
- 26:01Speaker 9: and out of every four dollars spent. That said, you know,
- 26:06Speaker 9: and like, don't bring into account the potential benefits of
- 26:12Speaker 9: having people who are not spending their entire day on dialysis,
- 26:16Speaker 9: you know, who are contributing to the economy.
- 26:18Speaker 6: You know.
- 26:18Speaker 9: That said, some of the early indications are and the
- 26:24Speaker 9: CBO has done has kind of done a little bit
- 26:27Speaker 9: of thinking about this. Is the cost is still too high,
- 26:30Speaker 9: you know, and.
- 26:31Speaker 4: The and the supply is kind of being limited at
- 26:34Speaker 4: this time.
- 26:34Speaker 8: So what do you I mean, do you ration it out?
- 26:36Speaker 4: What do you do at this point?
- 26:38Speaker 9: Yeah, the supply being limited means that the likes of
- 26:41Speaker 9: Novo Nordisk have limited who these drugs go to first, essentially,
- 26:49Speaker 9: and they're going to the diabetic patients first because it
- 26:51Speaker 9: has it's more meaningful for them on a whole on
- 26:54Speaker 9: an aggregate basis, immediately, but you know, they're rimming up supply.
- 27:00Speaker 9: The problem is the demand is so huge, how do
- 27:03Speaker 9: you ever bring down costs meaningfully enough to make it
- 27:08Speaker 9: worth it. Now, it should be noted that some of
- 27:10Speaker 9: these costs that we've talked about here are pre rebate,
- 27:13Speaker 9: So prescription costs for Medicaid essentially have due to manufacture rebates.
- 27:19Speaker 9: Since these are the same and but these are the
- 27:22Speaker 9: numbers we're kind of talking about, I think they give
- 27:24Speaker 9: a good indication of how significant this is going to be.
- 27:26Speaker 2: Well, I like, I mean, I'm I'm a big fan
- 27:28Speaker 2: of North the state of the state of North Carolina,
- 27:30Speaker 2: not necessarily the University of North Carolina being a duke
- 27:33Speaker 2: red But here I noticed in your reporting here that
- 27:35Speaker 2: the debate has played out most heatedly in North Carolina,
- 27:39Speaker 2: where Novo Nordis has three plants that make drugs for
- 27:42Speaker 2: obesity and diabetes. Yet they're at the forefront of the
- 27:46Speaker 2: state trying to limit who you know, what the state
- 27:50Speaker 2: will pay for it. So very ironic there and.
- 27:52Speaker 9: Here there's also this incredible calculus as well. So Dale Folwell,
- 27:58Speaker 9: who will speak to later today on radio as well
- 28:00Speaker 9: as on Bloomberg TV. He you know, it runs this
- 28:05Speaker 9: plan and apparently the Prescription Benefit Manager CVS, he says,
- 28:10Speaker 9: told him that if they start restricting the population who
- 28:14Speaker 9: can get drugs, Novo Nordisk will cut the rebates they get,
- 28:20Speaker 9: so they'll have to pay much closer to thirteen forty
- 28:23Speaker 9: nine the list price of you know, we go via
- 28:25Speaker 9: the weight loss version of one of these drugs.
- 28:28Speaker 2: That's nine dollars yes for a month.
- 28:32Speaker 9: Yes, versus the seven hundred and seventy two that they
- 28:35Speaker 9: were currently paid. So that makes the calculus even worse. Right, So,
- 28:39Speaker 9: I mean, essentially, if manufacturers threatened to cut these rebates
- 28:42Speaker 9: because people are restricting that, I mean, it's this whole
- 28:44Speaker 9: vicious cycle.
- 28:45Speaker 4: But I mean they're pushing it.
- 28:46Speaker 6: You know.
- 28:47Speaker 4: Eli Lilly said it's going to launch this digital healthcare platform,
- 28:50Speaker 4: you know, and that's really going to pressure They're going
- 28:52Speaker 4: to home deliver some of these these medications.
- 28:54Speaker 2: So they're they're pushing it.
- 28:55Speaker 9: And they're doing impact studies talking about the costs of
- 28:58Speaker 9: obesity that Lily has publicized a bunch of those or
- 29:02Speaker 9: funded a bunch of those. H they are lobbying state
- 29:06Speaker 9: and federal officials. Mind you, Medicare is a federal thing.
- 29:10Speaker 9: And there are some officials on Capitol Hill who are
- 29:12Speaker 9: saying Medicare should cover this for Medicare beneficiaries, just for
- 29:16Speaker 9: weight loss too. I mean, anytime you hear about this,
- 29:20Speaker 9: it's expanding the potential population of people who could get
- 29:23Speaker 9: these and don't. That doesn't even begin to take in
- 29:26Speaker 9: the kind of marketing that we're.
- 29:27Speaker 2: Seeing, all right. I mean, great reporting here, Simone, Simone Foxman,
- 29:32Speaker 2: you know, with this story and along with your co
- 29:35Speaker 2: reporter Laura nas Nomius. So, Laura Namias, Simone Foxman, great
- 29:40Speaker 2: reporting here, great story of Zempic's mania's billions and bills
- 29:44Speaker 2: are coming for US taxpayers. Check it out on the
- 29:47Speaker 2: Bloomberg terminal Bloomberg dot com. It really it's really good.
- 29:50Speaker 2: It's got a lot of data that I have not
- 29:52Speaker 2: seen before in terms of the cost and how the
- 29:54Speaker 2: costs are broken down, what are the drugs that are
- 29:56Speaker 2: in the marketplace, who's who's in there, and where's the
- 30:00Speaker 2: the money going and where's the money coming from. Some
- 30:02Speaker 2: great reporting, Simone, thanks so much.
- 30:04Speaker 5: You're listening to the tape. Can's are Live program Bloomberg
- 30:08Speaker 5: Markets weekdays at ten am Eastern on Bloomberg Radio, the
- 30:11Speaker 5: tune in app, Bloomberg dot Com, and.
- 30:13Speaker 6: The Bloomberg Business App.
- 30:15Speaker 5: You can also listen live on Amazon Alexa from our
- 30:17Speaker 5: flagship New York station, Just say Alexa play Bloomberg eleven thirty.
- 30:24Speaker 2: My next life. I want to come back as a
- 30:26Speaker 2: healthcare m and a banker. Those guys get paid every day.
- 30:30Speaker 2: It seems like every Monday we come in and there's
- 30:32Speaker 2: another mega healthcare deal. So let's see if that's going
- 30:36Speaker 2: to continue here. Kristin Pathier, Principal National and Global HCLs
- 30:42Speaker 2: Deal Advisor and Strategy Leader, Christian, We've got to deal
- 30:45Speaker 2: with that title there. We got to work on that. KPMG.
- 30:48Speaker 2: I mean, let's just say you're the global deal person.
- 30:51Speaker 2: That's what I'm going to go with. At KPMG, they
- 30:53Speaker 2: know what's going on out there in the world. So
- 30:56Speaker 2: Kristin talk to us about the landscape for healthcare MNA.
- 31:00Speaker 2: It just seems like it's just a it's almost like
- 31:03Speaker 2: a way of doing business for this industry. If you
- 31:06Speaker 2: can't come up with the drug or the therapeutic or
- 31:10Speaker 2: whatever in your own R and D, you go out
- 31:12Speaker 2: and buy it. Is that kind of where we are.
- 31:15Speaker 10: Absolutely and when you look at healthcare and life sciences
- 31:18Speaker 10: in general, it really is one of those recession proof industries.
- 31:21Speaker 10: People are getting sick. People get sick worldwide. They need
- 31:25Speaker 10: better medication, they can need faster medication, they need more
- 31:28Speaker 10: access to therapeutics, diagnostics, devices, And regardless of whether we're
- 31:33Speaker 10: in a major pandemic or whether we're in a major recession,
- 31:37Speaker 10: we still have people that are getting sick. And so
- 31:40Speaker 10: all of our groups in this space, whether they be
- 31:43Speaker 10: healthcare firms, life.
- 31:45Speaker 8: Sciences firms, they have to continue to innovate.
- 31:47Speaker 10: And innovation in medicine is precision medicine. It is the
- 31:52Speaker 10: future of medicine. It is generative AI. It is putting
- 31:55Speaker 10: together a number of different types of pieces of the
- 31:59Speaker 10: ecosystem so that we get to our patients faster.
- 32:01Speaker 8: So you are absolutely right.
- 32:03Speaker 10: Both inorganic and organic strategies are absolutely essential in this space,
- 32:08Speaker 10: and that is what we have seen throughout the years.
- 32:11Speaker 10: Even as the deal market has softened over the past
- 32:14Speaker 10: couple of years.
- 32:15Speaker 4: You know, I want to get more into that innovation
- 32:17Speaker 4: that you were talking about. I hosted a panel for Bloomberg.
- 32:19Speaker 4: It was about AI and one of the companies there
- 32:23Speaker 4: was healthcare and they said, AI is playing a big part.
- 32:26Speaker 4: It is a game changer. So if you can get
- 32:29Speaker 4: a little bit more into that.
- 32:30Speaker 10: For us, absolutely, and it's a game changer across all
- 32:33Speaker 10: of the different subsectors of healthcare and life sciences. Remember
- 32:37Speaker 10: there are a number of different groups that are playing
- 32:39Speaker 10: into this ecosystem.
- 32:40Speaker 8: Our pharma companies.
- 32:42Speaker 10: Need generative AI to really help take their rapidity of
- 32:46Speaker 10: their pipelines, make everything going through the pipeline a lot faster,
- 32:50Speaker 10: a lot more efficient, a lot more effective. Our health
- 32:53Speaker 10: systems are using it both in the front office and
- 32:55Speaker 10: the back office to take all of the patient data,
- 32:58Speaker 10: all the patient claims, everything that they're getting hit with,
- 33:02Speaker 10: and develop new patient journeys, new sample journeys for those
- 33:06Speaker 10: patients to get them better and more effective therapeutics.
- 33:09Speaker 8: And what I would say is that over.
- 33:11Speaker 10: The last year alone, the amount of time and energy
- 33:16Speaker 10: and diligence that has been spent on generative AI, the companies,
- 33:20Speaker 10: the partnerships, how we're even dealing with the space has
- 33:23Speaker 10: just gone snowballed throughout the industry, and so we're getting
- 33:28Speaker 10: more and more questions on that every day. I would
- 33:30Speaker 10: say that the amount of deal making, actual m and
- 33:34Speaker 10: a in generative AI is less so than the partnerships
- 33:38Speaker 10: and all of the questions around generative AI, but in
- 33:41Speaker 10: twenty twenty four, we expect that to increase.
- 33:43Speaker 2: So what is precision medicine exactly?
- 33:48Speaker 10: And from your perspective, absolutely, precision medicine is the best
- 33:53Speaker 10: therapeutic or care for the best patient at the best time.
- 33:57Speaker 8: And so when you.
- 33:58Speaker 10: Think about that and you think about what I just said,
- 34:01Speaker 10: it isn't a buzzword.
- 34:03Speaker 8: It's the future of medicine.
- 34:04Speaker 10: We want to be able to take one patient, look
- 34:07Speaker 10: at that patient, and provide them the most effective and
- 34:11Speaker 10: efficient care.
- 34:12Speaker 8: And so that's what we see. And when we take
- 34:15Speaker 8: that precision.
- 34:16Speaker 10: Medicine out to precision healthcare, it adds in the entire ecosystem,
- 34:20Speaker 10: whether it be the diagnostics that surround those therapeutics, whether
- 34:24Speaker 10: it be the patient services, and whether it be in
- 34:26Speaker 10: a domestic market or a worldwide market.
- 34:29Speaker 4: Now, talk to about hospitals, they're facing these big financial pressures.
- 34:33Speaker 4: You have workers, there's a shortage of workers. How is
- 34:36Speaker 4: this going to change the industry moving into twenty twenty four.
- 34:39Speaker 10: Absolutely, both generative AI and precision health health happen to
- 34:45Speaker 10: really help what you just mentioned when you think about
- 34:48Speaker 10: how many workers we have to put in the workforce,
- 34:50Speaker 10: when you think about how many therapeutics that we need
- 34:53Speaker 10: to save people's lives. If we can get more precise diagnostics,
- 34:56Speaker 10: more precise services to our patients in amount of time
- 35:00Speaker 10: in those health systems, that allows us to take our
- 35:04Speaker 10: workforce and refine our workforce to only who we need.
- 35:08Speaker 10: It also allows us to upscale our workforce, maybe with
- 35:11Speaker 10: bringing in people that could be upskilled faster through generative
- 35:15Speaker 10: AI approaches, and then allow us to manipulate and change
- 35:19Speaker 10: our workforce to better suit the needs of what we
- 35:21Speaker 10: need in the future.
- 35:23Speaker 2: All Right, So, from a deal perspective, Kristen, what sectors
- 35:27Speaker 2: do you think are going to be most in play
- 35:29Speaker 2: over the next twelve months.
- 35:33Speaker 10: When you look across healthcare and life sciences and you
- 35:35Speaker 10: look at the lows of twenty twenty three and you
- 35:38Speaker 10: look at what's recovering quicker, each one of the subsectors
- 35:41Speaker 10: in life sciences continues to be very exciting in for
- 35:45Speaker 10: different reasons. Within biopharma, the innovation around selling gene therapy
- 35:49Speaker 10: within a lot of our other biologics within Companion Therapeutics
- 35:53Speaker 10: is continuing to move us through the pipeline and look
- 35:57Speaker 10: at deals that are continuing to change the portfolio.
- 36:01Speaker 8: Of each one of our pharmaceutical companies.
- 36:03Speaker 10: When you look at diagnostics, we had a little bit
- 36:05Speaker 10: of a lull last year, of course, as our diagnostics
- 36:08Speaker 10: companies went into the new normal post COVID, But now
- 36:12Speaker 10: they are looking for interesting point of care and interesting
- 36:16Speaker 10: innovations within diagnostics to help pharmaceutical companies and to help
- 36:19Speaker 10: services in better ways. Devices are always going to be
- 36:24Speaker 10: one of those areas where we keep on looking to say,
- 36:27Speaker 10: is this the year device companies had a harder time
- 36:31Speaker 10: during COVID? Of course, as elective procedures really tanked. All
- 36:34Speaker 10: those elective procedures, hips, knees, etc. All have come up again,
- 36:39Speaker 10: and now as our health systems continue to promote those
- 36:42Speaker 10: elective procedures continue to bring them in, our device companies
- 36:46Speaker 10: are looking very carefully at new innovative ways that they
- 36:49Speaker 10: can bring new devices to the fold and emerge as
- 36:52Speaker 10: the victors in that particular area.
- 36:55Speaker 8: In healthcare, when you.
- 36:56Speaker 10: Look at health systems, when you look at payers, when
- 36:59Speaker 10: you look at physician groups, we're seeing health it and
- 37:02Speaker 10: physician groups as being the most exciting areas and continued
- 37:07Speaker 10: consolidation and thoughts on health systems as the health systems
- 37:10Speaker 10: continue to recover from COVID and really be very thoughtful
- 37:14Speaker 10: about their costs, paired with the innovation that they're seeing
- 37:17Speaker 10: from life sciences. Life sciences and healthcare are inactuably linked sectors,
- 37:22Speaker 10: and so as we look at this overall, we're continuing
- 37:26Speaker 10: to see the dynamics between innovation between those two teams.
- 37:30Speaker 2: Kristin, thanks so much for joining us. Really fascinating stuff there.
- 37:33Speaker 2: Kristin Pathier, Principal National and Global HCLs Deal Advisory and
- 37:37Speaker 2: Strategy leader for KPMG.
- 37:39Speaker 5: You're listening to the tape cans our live program, Bloomberg
- 37:43Speaker 5: Markets weekdays at ten am Eastern on Bloomberg Radio, the
- 37:46Speaker 5: tune in app, Bloomberg dot Com, and the.
- 37:48Speaker 6: Bloomberg Business App.
- 37:49Speaker 5: You can also listen live on Amazon Alexa from our
- 37:52Speaker 5: flagship New York station, Just say Alexa play Bloomberg eleven thirty.
- 37:58Speaker 2: Let's talk about this jobs market again. It is resilient,
- 38:02Speaker 2: it is robust. I don't know what you it doesn't matter.
- 38:05Speaker 2: It just seems like you can't crack this labor market
- 38:07Speaker 2: that continues to be some pretty solid demand. Julia Pollock
- 38:10Speaker 2: joins us. She's a chief economist at ZipRecruiter. So, Julie,
- 38:13Speaker 2: we got some better than I think expected jobs dated
- 38:16Speaker 2: today in terms of the number of jobs and then
- 38:18Speaker 2: also the wages. What are you seeing at there at
- 38:20Speaker 2: ZipRecruiter when you look at there at the labor market,
- 38:22Speaker 2: it was a mixed jobs report.
- 38:24Speaker 11: But yes, you know, zooming out twenty twenty three was
- 38:27Speaker 11: a remarkable year in the labor market. We not just
- 38:30Speaker 11: dodged a recession, we completely completely avoided a recession in
- 38:35Speaker 11: the labor market, even though it did slow substantially. And
- 38:41Speaker 11: not only that, it was actually one of the best
- 38:42Speaker 11: years on record when it comes to the unemployment rate,
- 38:45Speaker 11: the average unemployment rate, it ties for fifth place with
- 38:47Speaker 11: nineteen sixty eight. Wow, So pretty strong year overall.
- 38:51Speaker 4: And talk about some of the trends that are going on.
- 38:53Speaker 4: We used to talk about that trend of job switching.
- 38:56Speaker 2: Is that still safe?
- 38:58Speaker 4: Ords it best to just stay in place.
- 39:01Speaker 11: So the data that came out earlier in the week,
- 39:04Speaker 11: the JAULTZ data showed a pretty substantial decline in job switching.
- 39:09Speaker 11: So the quits rate fell to the lowest rate since
- 39:12Speaker 11: before since early twenty eighteen, and that suggests that the
- 39:17Speaker 11: Great resignation is fully completely over. And the higher's rate
- 39:21Speaker 11: also plunged to the lowest level since twenty fourteen. And
- 39:25Speaker 11: so the reason that overall employment levels are going up
- 39:29Speaker 11: is not because of aggressive hiring. It's more because of
- 39:32Speaker 11: very slow turnover and churn. And what we're seeing at
- 39:36Speaker 11: ZIP recruiter is a continued, gradual, orderly cooling in the
- 39:40Speaker 11: label market that's likely to persist until the FED takes
- 39:44Speaker 11: its foot off the rate piel and allows the economy
- 39:48Speaker 11: to invest in boom again.
- 39:50Speaker 2: So, Julia, what is I guess employee hoarding? Is it
- 39:56Speaker 2: a thing? Is it real?
- 39:58Speaker 11: So if you at layoffs and firings, they have been
- 40:03Speaker 11: about twenty percent lower this year than was normal between
- 40:06Speaker 11: twenty sixteen and twenty nineteen. So we're seeing historically unusually
- 40:11Speaker 11: low firing and layoffs at a time when there are
- 40:14Speaker 11: many industries where activity has taken a huge knock from
- 40:19Speaker 11: high interest rates. If you look at the construction sector,
- 40:22Speaker 11: it's actually up over four hundred thousand jobs since before
- 40:26Speaker 11: the pandemic. Industries like banking where I think if you
- 40:31Speaker 11: look at a lot of the numbers it hasn't been
- 40:33Speaker 11: so great, right, Lots and lots of bank deposits have
- 40:35Speaker 11: left that SIB system, like on eight hundred and seventy
- 40:37Speaker 11: billion dollars. Bank stocks have fallen pretty substantially and underperformed
- 40:45Speaker 11: the S and P five hundred by the largest amount ever.
- 40:49Speaker 11: And yet overall employment in that sector has been flat
- 40:51Speaker 11: as a pancake. So yes, I think there is a
- 40:54Speaker 11: sign that employers are holding on to the workers they've got,
- 40:57Speaker 11: even in industries that are pretty slow, because they are
- 41:00Speaker 11: confident that things are going to turn around.
- 41:03Speaker 4: So and when you talk about that, you know, managing
- 41:05Speaker 4: this headcount, So is it that they're relying on attrition
- 41:09Speaker 4: or rather than doing layoffs? What do you say?
- 41:14Speaker 11: Yes, but even overall headcount numbers are staying pretty flat
- 41:18Speaker 11: and stable.
- 41:19Speaker 3: You know.
- 41:19Speaker 11: One exception is transportational warehousing, where we are seeing some
- 41:23Speaker 11: sort of right sizing in that sector now after it
- 41:26Speaker 11: posted the largest gains since the pandemic. So, you know,
- 41:30Speaker 11: as people get back to normal and spend more on
- 41:32Speaker 11: services and good spending slows, growth and good spending slows,
- 41:39Speaker 11: that industry is shedding jobs, but most are not. Employment
- 41:43Speaker 11: is pretty stable and flat and resilient. That's actually the
- 41:46Speaker 11: only sectors that are really contributing to growth at the
- 41:50Speaker 11: moment are these three largely acyclical sectors, the government, healthcare,
- 41:54Speaker 11: and leisure hospitality. They accounted for ninety two percent of
- 41:58Speaker 11: all jobs added in the last six months.
- 42:01Speaker 2: So, Julia, people are at work. My question is where
- 42:04Speaker 2: are they working. Are they working at home, are they
- 42:06Speaker 2: working in the office? Where are we on that these days?
- 42:10Speaker 11: So it's a very very mixed bag. Remote work has
- 42:14Speaker 11: pretty much stabilized now at around twenty five to twenty
- 42:17Speaker 11: eight percent of all worked days, up from about five
- 42:20Speaker 11: percent before the pandemic. And this is the year when
- 42:24Speaker 11: that really stabilized. The Many companies brought workers back to
- 42:28Speaker 11: the office, but many other companies started afresh in a
- 42:31Speaker 11: remote first posture, and among companies the flexibility became the norm.
- 42:39Speaker 11: The five day in office work week became very rare.
- 42:43Speaker 11: Only sixteen percent of companies with office.
- 42:46Speaker 2: So I'm one of the special people's five days.
- 42:48Speaker 11: You're one of those.
- 42:50Speaker 2: I know, I was specialty.
- 42:51Speaker 11: Most people get at least one, two, three or four
- 42:53Speaker 11: days off, so I hear out out of the office
- 42:57Speaker 11: a week.
- 42:58Speaker 4: And we've learn a lot of us in twenty twenty
- 43:00Speaker 4: three about the great resignation is that gone in the
- 43:04Speaker 4: days of twenty twenty four.
- 43:06Speaker 11: It's gone. Turnovers not just back to pre pandemic normal,
- 43:09Speaker 11: it's actually lower. It's about where it was in early
- 43:12Speaker 11: twenty eighteen. And that is a really reliable measure of
- 43:19Speaker 11: how much economic opportunity there really is for unemployed workers,
- 43:24Speaker 11: for workers to find better jobs. And I think it
- 43:28Speaker 11: suggests that there is some cooling in this live market
- 43:31Speaker 11: and that workers are finding it a little bit harder
- 43:34Speaker 11: to find new jobs and to find the kinds of
- 43:36Speaker 11: jobs that they want right now.
- 43:38Speaker 2: All right, my I guess employment ready offspring, they're all employed.
- 43:43Speaker 2: But how about folks coming out of college and graduate school.
- 43:46Speaker 2: How's that entry market right now?
- 43:50Speaker 11: So, surveys of employers suggest that they are projecting hiring
- 43:55Speaker 11: fewer members of the graduating class of twenty twenty four
- 43:58Speaker 11: than of previous classes. That said, those projections can change.
- 44:03Speaker 11: It's quite possible that twenty twenty four could be like
- 44:07Speaker 11: twenty twenty three again, in that companies start the year
- 44:11Speaker 11: expecting to cut headcount and cut costs more aggressively and
- 44:14Speaker 11: then realize, wait a second, there's nerve recession. On hand,
- 44:17Speaker 11: the consumer is still strong. I need workers and actually
- 44:21Speaker 11: hire more than they're expecting at the start of the year,
- 44:23Speaker 11: especially if we see interest rates come down and investment
- 44:27Speaker 11: rise again.
- 44:28Speaker 4: And new year people out there looking for a new job.
- 44:31Speaker 4: Do you have to rip up the script when it
- 44:33Speaker 4: comes to your resume? I mean, if you want to
- 44:35Speaker 4: start all over again, what should you do differently when
- 44:38Speaker 4: you're putting it together? Is it more about skills? What
- 44:40Speaker 4: should you have on there that really stands out?
- 44:43Speaker 8: Yeah?
- 44:43Speaker 11: So this is not a chronology. It's more like an
- 44:46Speaker 11: advertising pamphlet, showing your most your greatest hits, your most
- 44:50Speaker 11: relevant skills and experience. That's I think how people should
- 44:53Speaker 11: think about their resumes. Put the relevant experience up first,
- 44:57Speaker 11: and then you know, it's really important these days to
- 45:01Speaker 11: have a digital jobs or seecret profile. So upload your resume,
- 45:06Speaker 11: make sure it can be read by computers and parsed
- 45:08Speaker 11: by these job marketplaces, so that you're actually getting your
- 45:13Speaker 11: foot through the door and getting past the robots into
- 45:16Speaker 11: a human.
- 45:17Speaker 2: How about it In the trades, people tell me that
- 45:20Speaker 2: there's still a shortage of trades men and women out there.
- 45:24Speaker 2: How does that part of the market look to you.
- 45:28Speaker 11: Yes, So there are many industries with aging workforces, with
- 45:34Speaker 11: a lot of retirements and with shrinking pipelines of new talent.
- 45:38Speaker 11: New younger generations of workers are not as interested in
- 45:41Speaker 11: those roles. They also are seeing a work a labor
- 45:46Speaker 11: force with a lot more flexible opportunities, and so they're
- 45:49Speaker 11: going to the remote jobs and the tech jobs and
- 45:51Speaker 11: the influencer jobs. There's tremendous interest still in marketing roles
- 45:55Speaker 11: and pr roles and those kinds of things, and much
- 45:57Speaker 11: less interest in doing hard labor in manufacturing or construction.
- 46:04Speaker 11: That said, wages in those fields are rising in order
- 46:07Speaker 11: to deal with the supply shortage, and perhaps you'll see
- 46:11Speaker 11: a tipping point where people start to take more interest
- 46:14Speaker 11: in these roles.
- 46:15Speaker 4: And what about the gig sector. I've heard a lot
- 46:17Speaker 4: of talk about there's more freelancers out there, that's what
- 46:20Speaker 4: people are looking to do more. Is that still growing
- 46:23Speaker 4: into twenty twenty four or is that cut back? You
- 46:25Speaker 4: think this year a little cut back.
- 46:27Speaker 11: So unfortunately, official data on gigwork is not very good,
- 46:34Speaker 11: and we haven't really been tracking it over over time
- 46:37Speaker 11: in a consistent way, so it's kind of a bit
- 46:40Speaker 11: of a black box. It's hard to note. We can
- 46:42Speaker 11: look at the company's earning statements about how many users
- 46:47Speaker 11: they have. Look broadly, we do see a lot of
- 46:51Speaker 11: interest among job seekers on zip recruiter in those kinds
- 46:53Speaker 11: of gig roles because of the flexibility they offer. There
- 46:56Speaker 11: are many young people who sort of live from hand
- 46:59Speaker 11: to mouth and have fun and watch video games and
- 47:01Speaker 11: do what they want to do. And if they need
- 47:03Speaker 11: cash and need a buy groceries, need to buy dinner,
- 47:05Speaker 11: they know, log onto an app and deliver groceries for
- 47:08Speaker 11: a couple hours and then buy their own and then
- 47:10Speaker 11: go back to doing what they're doing. That it is
- 47:12Speaker 11: quite common to work that way these days. That said,
- 47:15Speaker 11: there's some new research showing that once AI tools chatch
- 47:20Speaker 11: GVD was launched, generative AI demand for other kinds of
- 47:23Speaker 11: freelancers started to fall. So interesting, all right, we'll get
- 47:28Speaker 11: a white collar freelancer.
- 47:29Speaker 2: Yeah, you just walked across or walk through any local
- 47:32Speaker 2: coffee shop and I'm like, what are these people doing here?
- 47:34Speaker 2: You know, they all got to laptops out and they
- 47:36Speaker 2: look like they're doing something committing value. I don't know.
- 47:38Speaker 1: Thanks for listening to the Bloomberg Markets Podcast. You can
- 47:41Speaker 1: subscribe and listen to interviews at Apple Podcasts or whatever
- 47:45Speaker 1: podcast platform you prefer. I'm Matt Miller. I'm on Twitter
- 47:49Speaker 1: at Matt Miller nineteen seventy three.
- 47:51Speaker 2: And I'm Paul Sweeney. I'm on Twitter at pt Sweeney.
- 47:54Speaker 2: Before the podcast, you can always catch us worldwide at
- 47:56Speaker 2: Bloomberg Radio